Gohealth Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
2024-11-09
Gohealth Inc reports results for the quarter ended September 30 - Earnings Summary
  • Gohealth Inc GOCO.OQ reported quarterly adjusted earnings of 46 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-2.61. The mean expectation of four analysts for the quarter was for a loss of $3.19 per share. Wall Street expected results to range from $-3.91 to $-2.69 per share.

  • Revenue fell 10.4% to $118.29 million from a year ago; analysts expected $106.92 million.

  • Gohealth Inc's reported EPS for the quarter was 46 cents​.

  • The company reported quarterly net income of $6.78 million.

  • Gohealth Inc shares had risen by 25.6% this quarter and lost 11.7% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts was unchanged in the last three months.​

  • In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

  • The average consensus recommendation for the multiline insurance & brokers peer group is also "buy"

Wall Street's median 12-month price target for Gohealth Inc is 18.00

This summary was machine generated from LSEG data November 8 at 04:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Sep. 30 2024

-3.19

0.46

Beat

Jun. 30 2024

-2.47

-2.70

Missed

Mar. 31 2024

-0.95

-1.04

Missed

Dec. 31 2023

2.73

-0.22

Missed

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10